Syneos Health has signed a new three-year agreement with Pfizer to provide global product development services to support Pfizer’s portfolio. Pfizer has the right to extend the term for up to an additional two years. Financial details were not disclosed. This agreement builds on a longstanding relationship where Syneos Health has provided services across the clinical and commercial continuum to support product development. The company will continue to provide a broad range of services ...